4521 KAKEN PHARMACEUTICAL CO.,LTD.科研製薬TSE Prime / Pharmaceuticals
0 posts
KAKEN PHARMACEUTICAL CO.,LTD. (4521) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
KAKEN PHARMACEUTICAL CO.,LTD. (4521) Stock Price HistoryNear a 52-week low
KAKEN PHARMACEUTICAL CO.,LTD. closed at ¥3,805 on Nov 20, 2026, −1.0% over 1 month, +3.0% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥98,960 today (−1.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −1.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥3,805 | −10 | −0.26% |
| Nov 19 (Thu) | ¥3,815 | +0 | +0.00% |
| Nov 18 (Wed) | ¥3,815 | −25 | −0.65% |
| Nov 17 (Tue) | ¥3,840 | +5 | +0.13% |
| Nov 16 (Mon) | ¥3,835 | +10 | +0.26% |
| Nov 13 (Fri) | ¥3,825 | −15 | −0.39% |
| Nov 12 (Thu) | ¥3,840 | +50 | +1.32% |
| Nov 11 (Wed) | ¥3,790 | +25 | +0.66% |
| Nov 10 (Tue) | ¥3,765 | −35 | −0.92% |
| Nov 9 (Mon) | ¥3,800 | +60 | +1.60% |
If you had invested ¥100,000 3 months ago, it would be worth ¥95,006 today (−5.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −5.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥3,805 | −10 | −0.26% |
| Nov 19 (Thu) | ¥3,815 | +0 | +0.00% |
| Nov 18 (Wed) | ¥3,815 | −25 | −0.65% |
| Nov 17 (Tue) | ¥3,840 | +5 | +0.13% |
| Nov 16 (Mon) | ¥3,835 | +10 | +0.26% |
| Nov 13 (Fri) | ¥3,825 | −15 | −0.39% |
| Nov 12 (Thu) | ¥3,840 | +50 | +1.32% |
| Nov 11 (Wed) | ¥3,790 | +25 | +0.66% |
| Nov 10 (Tue) | ¥3,765 | −35 | −0.92% |
| Nov 9 (Mon) | ¥3,800 | +60 | +1.60% |
If you had invested ¥100,000 6 months ago, it would be worth ¥91,576 today (−8.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −8.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥3,805 | −0.7% |
| Oct 2026 | ¥3,830 | −0.5% |
| Sep 2026 | ¥3,850 | −3.8% |
| Aug 2026 | ¥4,000 | +5.4% |
| Jul 2026 | ¥3,795 | −1.3% |
| Jun 2026 | ¥3,845 | −3.4% |
| May 2026 | ¥3,980 | −2.5% |
If you had invested ¥100,000 1 year ago, it would be worth ¥102,977 today (+3.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved +3.0%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥3,805 | −0.7% |
| Oct 2026 | ¥3,830 | −0.5% |
| Sep 2026 | ¥3,850 | −3.8% |
| Aug 2026 | ¥4,000 | +5.4% |
| Jul 2026 | ¥3,795 | −1.3% |
| Jun 2026 | ¥3,845 | −3.4% |
| May 2026 | ¥3,980 | −2.5% |
| Apr 2026 | ¥4,080 | −1.4% |
| Mar 2026 | ¥4,140 | −6.7% |
| Feb 2026 | ¥4,435 | +9.1% |
| Jan 2026 | ¥4,065 | +1.2% |
| Dec 2025 | ¥4,015 | +3.7% |
| Nov 2025 | ¥3,870 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥114,402 today (+14.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved +14.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥3,805 | −5.2% |
| 2025 | ¥4,015 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥91,908 today (−8.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −8.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥3,805 | −5.2% |
| 2025 | ¥4,015 | ― |
If you had invested ¥100,000 in Jan 2001, it would be worth ¥305,377 today (+205.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +334.1%, while this stock moved +205.4%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥3,805 | −5.2% |
| 2025 | ¥4,015 | −11.0% |
| 2024 | ¥4,513 | +34.5% |
| 2023 | ¥3,355 | −13.8% |
| 2022 | ¥3,890 | −7.6% |
| 2021 | ¥4,210 | +5.6% |
| 2020 | ¥3,985 | −34.0% |
| 2019 | ¥6,040 | +24.2% |
| 2018 | ¥4,865 | −16.4% |
| 2017 | ¥5,820 | −6.1% |
| 2016 | ¥6,200 | −25.4% |
| 2015 | ¥8,310 | +77.8% |
| 2014 | ¥4,674 | +47.9% |
| 2013 | ¥3,160 | +24.3% |
| 2012 | ¥2,542 | +24.2% |
| 2011 | ¥2,046 | +3.8% |
| 2010 | ¥1,972 | +24.8% |
| 2009 | ¥1,580 | −20.0% |
| 2008 | ¥1,976 | +26.0% |
| 2007 | ¥1,568 | −15.6% |
| 2006 | ¥1,858 | +1.1% |
| 2005 | ¥1,838 | +36.1% |
| 2004 | ¥1,350 | +25.5% |
| 2003 | ¥1,076 | +9.1% |
| 2002 | ¥986 | −31.0% |
| 2001 | ¥1,428 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jan 2001). Please check the latest prices before trading.
KAKEN PHARMACEUTICAL CO.,LTD. (4521) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of KAKEN PHARMACEUTICAL CO.,LTD. (4521)
Business overview
Together with four consolidated subsidiaries, the company runs pharmaceutical and real estate businesses. The pharmaceutical business makes and sells pharmaceuticals, medical devices and agricultural chemicals, handled by the company and subsidiaries such as 「科研ファルマ」 and 「アーサム」. In the real estate business, the company leases property.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 4.99% | No. 3 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 22.2x | Above the sector median of 16.5x (No. 25 from the lowest) |
| PBR | 0.94x | Below the sector median of 1.86x (No. 18 from the lowest) |
| ROE | 4.24% | No. 27 in the sector (highest first); median 4.17% |
| Market cap | ¥144.1 bn | No. 20 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥4,435 | 2/27 |
|---|---|---|
| 52-week low | ¥3,695 | 2025/11/20 |
| Current position | 14.9% | Where the low is 0% and the high is 100% (close on 11/20: ¥3,805) |
| Year to date | -5.2% | No. 31 of 77 in the sector (best first) |
| 1 year | +3.0% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/09 15:30連結子会社の吸収合併(簡易合併・略式合併)に関するお知らせ
- 11/09 15:302027年3月期 第2四半期(中間期)決算 決算短信補足資料
- 11/09 15:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
Filings from the past 12 months (3).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the KAKEN PHARMACEUTICAL CO.,LTD. board
More Japanese stocks in English
- MORISHITA JINTAN CO.,LTD.4524
- RIKEN VITAMIN CO.,LTD.4526
- ROHTO PHARMACEUTICAL CO.,LTD.4527
- ONO PHARMACEUTICAL CO.,LTD.4528
- iShares S&P 500 Premium Income ETF452A
- Yuki Gosei Kogyo Co.,Ltd.4531
- Mochida Pharmaceutical Co.,Ltd.4534
- SANTEN PHARMACEUTICAL CO.,LTD.4536
- Fuso Pharmaceutical Industries,Ltd.4538
- NIPPON CHEMIPHAR CO.,LTD.4539
- iShares 20+ Year US Treasury Bond Premium Income ETF453A
- TSUMURA & CO.4540